Trial Profile
A Single-centre, Double Blind, Randomised, Rising Dose Tolerance Study to Investigate the Safety of Juvista When Administered Following Excision of Ear Lobe Keloids.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Avotermin (Primary)
- Indications Keloids
- Focus Adverse reactions
- Sponsors Renovo
- 21 May 2014 New trial record